Skip to content
MedsAcross

Medicine

Nicardipine 30 mg capsule

Nicardipine · Oral
Available on requestPrescription onlyUS FDAGeneric name

Nicardipine 30 mg capsule is a generic prescription medicine for oral use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20°C to 25°C (68°F to 77°F).

Key facts

Active ingredient (INN)
Nicardipine
Brand
Sold under the generic name
Strength
30 mg
Dosage form
Capsule
Route
Oral
Packs
500 capsules, 90 capsules, 100 capsules and 10 more
Manufacturers
Glenmark PharmaceuticalsIndiaEpic PharmaAmerisynAmici PharmaAmneal Pharmaceuticals NYANI PharmaceuticalsBionpharmaBlu PharmaceuticalsBurel Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20°C to 25°C (68°F to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C08CA04 Nicardipine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
5 May 2010
Identifiers
RxCUI 858613, 858616DailyMed set ID 3955d43d-a87f-4d2c-b90e-3ecf0d6aa148, cb902af0-b5ad-4680-b2f2-007ef2196efe, 065efabf-8c7d-4dd5-aef2-700c2eca399d +6NDC 68462-121, 35573-458, 24658-751 +6Application ANDA216357, ANDA215377, ANDA074928 +3

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
500 capsule in 1 bottle68462-121-05Glenmark PharmaceuticalsIndia16 December 2022
90 capsule in 1 bottle68462-121-90Glenmark PharmaceuticalsIndia16 December 2022
90 capsule in 1 bottle87564-028-90Amerisyn26 July 2026
90 capsule in 1 bottle69292-621-90Amici Pharma15 January 2026
90 capsule in 1 bottle69238-2692-1Amneal Pharmaceuticals NY3 October 2024
90 capsule in 1 bottle62559-206-90ANI Pharmaceuticals25 June 2021
90 capsule in 1 bottle, plastic69452-437-19Bionpharma4 November 2024
90 capsule in 1 bottle24658-751-90Blu Pharmaceuticals15 December 2016
90 capsule in 1 bottle35573-458-85Burel Pharmaceuticals8 January 2023
100 capsule in 1 bottle42806-502-01Epic Pharma5 May 2010
500 capsule in 1 bottle42806-502-05Epic Pharma5 May 2010
90 capsule in 1 bottle42806-502-09Epic Pharma5 May 2010
1000 capsule in 1 bottle42806-502-10Epic Pharma5 May 2010

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 21 December 1988Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Nicardipine

Clinical summary

Nicardipine is a dihydropyridine calcium channel blocker indicated for the short-term treatment of hypertension in adults when oral therapy is not feasible. It is available as injection and capsules for intravenous and oral use. MedsAcross supplies Nicardipine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Nicardipine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Nicardipine 30 mg capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.